Everest Organics P/B Ratio
Everest Organics (EVERESTO) P/B ratio is 3.48 (High), book value per share ₹70.00 vs Healthcare average P/B of -0.94 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see Everest Organics stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
EVERESTO P/B Ratio — Valuation Insights & Book Value Analysis
Everest Organics price-to-book ratio interpretation, valuation status and historical context — current P/B 3.48 (High). Compare with EVERESTO fair value to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 3.48, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.94
Everest Organics P/B Ratio Historical Trend
EVERESTO annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Everest Organics yearly highs lows for the annual high/low range and current price position.
EVERESTO Historical P/B Ratio — Book Value Per Share & Year-End Price
Everest Organics annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 7.23 | ₹70.0 | ₹505.80 | ₹70 | High |
| 2024 | 5.24 | ₹57.5 | ₹301.05 | ₹46 | High |
| 2023 | 2.2 | ₹57.5 | ₹126.65 | ₹46 | Moderate |
| 2022 | 2.1 | ₹58.75 | ₹123.35 | ₹47 | Moderate |
| 2021 | 4.24 | ₹58.75 | ₹249.10 | ₹47 | High |
EVERESTO vs Healthcare Peers — P/B Ratio Comparison
Everest Organics P/B 3.48 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |